Xconomy |
FDA grants 501(k) clearance for platform used in association to treat asthma, COPD
Healio “501(k) clearance of our platform with inhaler devices from leading global respiratory companies GlaxoSmithKline and Boehringer Ingelheim opens the doors for millions of patients to expect and achieve something better in asthma and COPD,” David Van … FDA Clears 2 New Propeller Health Devices That Track Respiratory Meds Propeller Health Receives FDA Clearance For The Propeller Platform In … FDA Approves Propeller Health Mobile Platform for GlaxoSmithKline's Diskus DPI … |
View full post on asthma – Google News